Abstract

Constitutive activation of STING by gain-of-function mutations triggers manifestation of the systemic autoinflammatory disease STING-associated vasculopathy with onset in infancy (SAVI). In order to investigate the role of signaling by tumor necrosis factor (TNF) in SAVI, we used genetic inactivation of TNF receptors 1 and 2 in murine SAVI, which is characterized by T cell lymphopenia, inflammatory lung disease and neurodegeneration. Genetic inactivation of TNFR1 and TNFR2, however, rescued the loss of thymocytes, reduced interstitial lung disease and neurodegeneration. Furthermore, genetic inactivation of TNFR1 and TNFR2 blunted transcription of cytokines, chemokines and adhesions proteins, which result from chronic STING activation in SAVI mice. In addition, increased transendothelial migration of neutrophils was ameliorated. Taken together, our results demonstrate a pivotal role of TNFR-signaling in the pathogenesis of SAVI in mice and suggest that available TNFR antagonists could ameliorate SAVI in patients.

Data availability

Transcriptomic data are deposited on GEO database, Accession no GSE244062.

The following data sets were generated

Article and author information

Author details

  1. Hella Luksch

    Department of Pediatrics, TU Dresden, Dresden, Germany
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-7070-4992
  2. Felix Schulze

    Department of Pediatrics, TU Dresden, Dresden, Germany
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-8220-5012
  3. David Geißler-Lösch

    Department of Neurology, TU Dresden, Dresden, Germany
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0009-0006-8332-2145
  4. David Sprott

    Department of Physiology, TU Dresden, Dresden, Germany
    Competing interests
    The authors declare that no competing interests exist.
  5. Lennart Höfs

    Department of Neurology, TU Dresden, Dresden, Germany
    Competing interests
    The authors declare that no competing interests exist.
  6. Eva M Szegö

    Department of Neurology, TU Dresden, Dresden, Germany
    Competing interests
    The authors declare that no competing interests exist.
  7. Wulf Tonnus

    Department of Internal Medicine III, TU Dresden, Dresden, Germany
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-9728-1413
  8. Stefan Winkler

    Department of Pediatrics, TU Dresden, Dresden, Germany
    Competing interests
    The authors declare that no competing interests exist.
  9. Claudia Günther

    Department of Dermatology, TU Dresden, Dresden, Germany
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-4330-1861
  10. Andreas Linkermann

    Department of Internal Medicine III, TU Dresden, Dresden, Germany
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-6287-9725
  11. Rayk Behrendt

    Institute for Clinical Chemistry and Clinical Pharmacology, University Hospital Bonn, Bonn, Germany
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-1091-2877
  12. Lino L Teichmann

    Department of Medicine III, University Hospital Bonn, Bonn, Germany
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-9489-7282
  13. Björn H Falkenburger

    Department of Neurology, TU Dresden, Dresden, Germany
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-2387-526X
  14. Angela Rösen-Wolff

    Department of Pediatrics, TU Dresden, Dresden, Germany
    For correspondence
    angela.roesen-wolff@uniklinikum-dresden.de
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-9613-5879

Funding

Deutsche Forschungsgemeinschaft (369799452-TRR237)

  • Felix Schulze

Deutsche Forschungsgemeinschaft (EXC2151 - 390873048)

  • Rayk Behrendt

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Animal experimentation: All mice experiments were approved by the Landesdirektion Sachsen (TVV 4/2019, TVV 13/2019) and carried out in accordance with the institutional guidelines on animal welfare.

Copyright

© 2025, Luksch et al.

This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 6
    downloads
  • 0
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Hella Luksch
  2. Felix Schulze
  3. David Geißler-Lösch
  4. David Sprott
  5. Lennart Höfs
  6. Eva M Szegö
  7. Wulf Tonnus
  8. Stefan Winkler
  9. Claudia Günther
  10. Andreas Linkermann
  11. Rayk Behrendt
  12. Lino L Teichmann
  13. Björn H Falkenburger
  14. Angela Rösen-Wolff
(2025)
Tissue inflammation induced by constitutively active STING is mediated by enhanced TNF signaling
eLife 14:e101350.
https://doi.org/10.7554/eLife.101350

Share this article

https://doi.org/10.7554/eLife.101350

Further reading

    1. Immunology and Inflammation
    2. Neuroscience
    Rocio Vicario, Stamatina Fragkogianni ... Frédéric Geissmann
    Research Article

    Somatic genetic heterogeneity resulting from post-zygotic DNA mutations is widespread in human tissues and can cause diseases, however, few studies have investigated its role in neurodegenerative processes such as Alzheimer’s disease (AD). Here, we report the selective enrichment of microglia clones carrying pathogenic variants, that are not present in neuronal, glia/stromal cells, or blood, from patients with AD in comparison to age-matched controls. Notably, microglia-specific AD-associated variants preferentially target the MAPK pathway, including recurrent CBL ring-domain mutations. These variants activate ERK and drive a microglia transcriptional program characterized by a strong neuro-inflammatory response, both in vitro and in patients. Although the natural history of AD-associated microglial clones is difficult to establish in humans, microglial expression of a MAPK pathway activating variant was previously shown to cause neurodegeneration in mice, suggesting that AD-associated neuroinflammatory microglial clones may contribute to the neurodegenerative process in patients.

    1. Immunology and Inflammation
    Sytse J Piersma, Shasha Li ... Wayne M Yokoyama
    Research Article

    Natural killer (NK) cells recognize target cells through germline-encoded activation and inhibitory receptors enabling effective immunity against viruses and cancer. The Ly49 receptor family in the mouse and killer immunoglobin-like receptor family in humans play a central role in NK cell immunity through recognition of major histocompatibility complex class I (MHC-I) and related molecules. Functionally, these receptor families are involved in the licensing and rejection of MHC-I-deficient cells through missing-self. The Ly49 family is highly polymorphic, making it challenging to detail the contributions of individual Ly49 receptors to NK cell function. Herein, we showed mice lacking expression of all Ly49s were unable to reject missing-self target cells in vivo, were defective in NK cell licensing, and displayed lower KLRG1 on the surface of NK cells. Expression of Ly49A alone on an H-2Dd background restored missing-self target cell rejection, NK cell licensing, and NK cell KLRG1 expression. Thus, a single inhibitory Ly49 receptor is sufficient to license NK cells and mediate missing-self in vivo.